ST-segment Elevation Myocardial Infarction Clinical Trial
Official title:
Comparative Study Between the Effects of High Doses Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction
STEMI is a serious type of coronary heart disease, which is a major cause of disability and death. Morphologically the key feature of remodeling is myocyte hypertrophy, myocyte loss from necrosis or apoptosis, as well as interstitial cell growth especially fibroblast proliferation leading to myocardial fibrosis . Elevated serum LDL-cholesterol concentrations play a proatherogenic role by stimulating inflammation and oxidative processes. Statins have been documented to retard fibrosis and ventricular hypertrophy by the cessation of myofibroblast activity. Clinical studies have proven that statins not only regulate lipids but also improve myocardial fibrosis, regulate cell proliferation and apoptosis, regulate ventricular remodeling, and protect the myocardium
1. Ethical committee approval will be obtained from Ethics committee of Faculty of Pharmacy, Damanhour University. 2. All participants should agree to take part in this clinical study and will provide informed consent. 3. (80) patients diagnosed with STEMI will be enrolled from Alexandria university hospital. 4. Serum samples will be collected from patients at the time of admission for measuring the biomarkers. 5. Echocardiogram also will be obtained at the time of admission. 6. All enrolled patients will be divided into two group to receive either Atorvastatin (40-80 mg) or Rosuvastatin (20-40mg). 7. All patients will be followed up during 3 months' period. At the end of 3 months, Serum samples will be collected from patients for measuring the biomarkers and Echocardiogram will be repeated. 8. Statistical tests appropriate to the study design will be conducted to evaluate the significance of the results. 9. Results, conclusion, discussion, and recommendations will be given. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05669222 -
The FAVOR V AMI Trial
|
N/A | |
| Recruiting |
NCT02894138 -
Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
|
Phase 3 | |
| Completed |
NCT02641262 -
Henan STEMI Registry
|
||
| Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
| Recruiting |
NCT01738100 -
Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
|
Phase 2 | |
| Completed |
NCT03671603 -
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
|
||
| Recruiting |
NCT02606435 -
Thrombus Aspiration in Patients With STEMI
|
Phase 4 | |
| Completed |
NCT01203982 -
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
|
Phase 4 | |
| Active, not recruiting |
NCT03338309 -
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
|
||
| Recruiting |
NCT02445885 -
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
| Not yet recruiting |
NCT04984915 -
The Usefulness of CaIMR in Patients With STEMI
|
||
| Active, not recruiting |
NCT03371784 -
The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
|
Phase 2/Phase 3 | |
| Completed |
NCT03389503 -
Comparison of Left and Right Transradial Approach for CAG and PCI
|
N/A | |
| Completed |
NCT02311231 -
Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
|
Phase 4 | |
| Completed |
NCT02324348 -
Efficacy and Safety Study of Deferred Stenting in Patients With STEMI
|
N/A | |
| Completed |
NCT01385631 -
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
|
Phase 4 | |
| Completed |
NCT03690713 -
International Collaboration of Comprehensive Physiologic Assessment
|
||
| Enrolling by invitation |
NCT02670005 -
Fractional Flow Reserve Versus Angiography for Guiding Selective Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction
|
N/A | |
| Completed |
NCT02164695 -
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
| Active, not recruiting |
NCT02070471 -
Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
|
Phase 2 |